Dicot initiates first studies in disease animal models
Press release: Uppsala, March 24, 2021. The potency drug developer Dicot has for the first time initiated studies in animals with erectile dysfunction. In earlier studies, the company's drug candidate has only been tested on healthy animals. The new studies are an important step in gaining approval for clinical trials in humans.In the past year, Dicot has conducted animal studies in collaboration with the French contract laboratory Pelvipharm, where the drug candidate LIB-01's effect on erectile function in healthy rats was tested. As previously reported, the company has been able to